as 35 has been researched along with leukotriene a4 in 1 studies
Studies (as 35) | Trials (as 35) | Recent Studies (post-2010) (as 35) | Studies (leukotriene a4) | Trials (leukotriene a4) | Recent Studies (post-2010) (leukotriene a4) |
---|---|---|---|---|---|
9 | 0 | 0 | 376 | 2 | 31 |
Protein | Taxonomy | as 35 (IC50) | leukotriene a4 (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamasaki, Y; Hayasaki, R; Ichimaru, T; Kobayashi, I; Matsuo, M; Miyazaki, M; Miyazaki, S; Muro, E; Tsuji, K; Yamamoto, S; Zaitu, M | 1 |
1 other study(ies) available for as 35 and leukotriene a4
Article | Year |
---|---|
(9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis.
Topics: Animals; Arachidonic Acid; beta-N-Acetylhexosaminidases; Cell-Free System; Cytosol; Leukotriene A4; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Phospholipases A; Pyridines; Pyrimidinones; Rats; Substrate Specificity; Tetrazoles; Tumor Cells, Cultured | 2000 |